Frontiers in Oncology | Radiation Oncology

Mini Review

Published on 16 Jan 2023

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer

in Radiation Oncology

Rodolfo Chicas-Sett
Juan Castilla Martinez
Abrahan Hernández Blanquisett
Juan Zafra
Jorge Pastor-Peidro

Frontiers in Oncology

doi 10.3389/fonc.2022.1092875

7,337 views
6 citations

Original Research

Published on 16 Jan 2023

Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases

in Radiation Oncology

Laura Uder
Marcel Nachbar
Sarah Butzer
Jessica Boldt
Sabrina Baumeister
Michael Bitzer
Alfred Königsrainer
Thomas Seufferlein
Rüdiger Hoffmann
Sergios Gatidis

Frontiers in Oncology

doi 10.3389/fonc.2022.1095633

4,162 views
12 citations

Original Research

Published on 16 Jan 2023

Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy

in Radiation Oncology

Jessica Prunaretty
Celine Bourgier
Sophie Gourgou
Claire Lemanski
David Azria
Pascal Fenoglietto

Frontiers in Oncology

doi 10.3389/fonc.2022.1066915

4,913 views
10 citations

Original Research

Published on 13 Jan 2023

High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes

in Radiation Oncology

Tanja Eichkorn
Jonathan W. Lischalk
Cedric Stüwe
Eric Tonndorf-Martini
Kai Schubert
Lisa-Antonia Dinges
Sebastian Regnery
Farastuk Bozorgmehr
Laila König
Petros Christopoulos

Frontiers in Oncology

doi 10.3389/fonc.2022.1035370

4,002 views

Original Research

Published on 13 Jan 2023

Machine-learning-based prediction of the effectiveness of the delivered dose by exhale-gated radiotherapy for locally advanced lung cancer: The additional value of geometric over dosimetric parameters alone

in Radiation Oncology

Nika Guberina
Christoph Pöttgen
Alina Santiago
Sabine Levegrün
Sima Qamhiyeh
Toke Printz Ringbaek
Maja Guberina
Wolfgang Lübcke
Frank Indenkämpen
Martin Stuschke

Frontiers in Oncology

doi 10.3389/fonc.2022.870432

2,682 views
7 citations

Original Research

Published on 13 Jan 2023

A novel hydrogel orthotopic injection model in moderately hypofractionated radiation therapy for prostate cancer: Adaptive degradation and durable imaging

in Radiation Oncology

Hao Yu
Cheng Wang
Lingyun Wu
Ziyang Zhou
Yiqi Wang
Wenxiang Li
Huili Yuan
Zeyi Lu
Danfang Yan
Si Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1077900

3,550 views
5 citations

Original Research

Published on 13 Jan 2023

Prediction of portal dosimetry quality assurance results using log files-derived errors and machine learning techniques

in Radiation Oncology

Kah Seng Lew
Clifford Ghee Ann Chua
Calvin Wei Yang Koh
James Cheow Lei Lee
Sung Yong Park
Hong Qi Tan

Frontiers in Oncology

doi 10.3389/fonc.2022.1096838

2,884 views
2 citations

Original Research

Published on 13 Jan 2023

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer

in Radiation Oncology

Jiaoxue He
Qingfeng Wang
Qiancheng Hu
Changlin Li

Frontiers in Oncology

doi 10.3389/fonc.2022.841356

3,055 views
1 citation

Original Research

Published on 12 Jan 2023

Treatment mode and prognosis of esophageal perforation after radiotherapy in patients with esophageal carcinoma

in Radiation Oncology

Zhen Chan-Jun
Bai Wen-Wen
Zhang Ping
Song Yu-Zhi
Wang Ya-Jing
Qiao Xue-Ying
Zhou Zhi-Guo

Frontiers in Oncology

doi 10.3389/fonc.2022.961902

3,005 views
1 citation

Original Research

Published on 11 Jan 2023

Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy

in Radiation Oncology

Matthew D. Hall
Kathryn E. Mittauer
Roberto Herrera
Katherine Von Werne
Rupesh Kotecha
Noah S. Kalman
James McCulloch
Diane Alvarez
Nicole C. McAllister
Delia G. Doty

Frontiers in Oncology

doi 10.3389/fonc.2022.1037674

3,548 views
2 citations

Original Research

Published on 09 Jan 2023

Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy

in Radiation Oncology

Christine Son
Melissa Y. Y. Moey
Paul R. Walker
Abdul R. Naqash
Matthew Sean Peach
Andrew W. Ju

Frontiers in Oncology

doi 10.3389/fonc.2022.1025455

3,850 views
10 citations

Case Report

Published on 06 Jan 2023

Primary squamous cell carcinoma of the breast: A case report and review of the literature

in Radiation Oncology

Yaping Wu
Zhiying Chen
Wei Li
Fengguang Wang
Yongchun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1033084

9,143 views
7 citations

Original Research

Published on 05 Jan 2023

Volumetric modulated arc therapy based total marrow and lymphoid irradiation: Workflow and clinical experience

in Radiation Oncology

Colton Ladbury
Chunhui Han
An Liu
Jeffrey Y. C. Wong

Frontiers in Oncology

doi 10.3389/fonc.2022.1042652

2,845 views
2 citations

Case Report

Published on 05 Jan 2023

Re-irradiation of recurrent vertebral metastasis after two previous spinal cord irradiation: A case report

in Radiation Oncology

Rita Bentahila
Rémy Kinj
Constance Huck
Yasmine El Houat
Ange Mampuya
Constantin Tuleasca
Mahmut Ozsahin
Jean Bourhis
Luis Schiappacasse

Frontiers in Oncology

doi 10.3389/fonc.2022.995376

4,481 views
2 citations

Original Research

Published on 04 Jan 2023

A predictive model for personalization of nanotechnology-based phototherapy in cancer treatment

in Radiation Oncology

Eli Varon
Gaddi Blumrosen
Orit Shefi

Frontiers in Oncology

doi 10.3389/fonc.2022.1037419

4,054 views
11 citations

Original Research

Published on 23 Dec 2022

Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer

in Radiation Oncology

Rishabh K. Simhal
Tamir N. Sholklapper
Anish K. Simhal
Alan L. Zwart
Malika T. Danner
Deepak Kumar
Nima Aghdam
Simeng Suy
Ryan A. Hankins
Keith J. Kowalczyk

Frontiers in Oncology

doi 10.3389/fonc.2022.1015264

2,906 views
2 citations

Original Research

Published on 21 Dec 2022

A liquid immunogenic fiducial eluter for image-guided radiotherapy

in Radiation Oncology

Michele Moreau
Geraud Richards
Sayeda Yasmin-Karim
Amol Narang
Curtiland Deville
Wilfred Ngwa

Frontiers in Oncology

doi 10.3389/fonc.2022.1020088

2,637 views
6 citations

Original Research

Published on 20 Dec 2022

Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions

in Radiation Oncology

Guang-Yi Sun
Ge Wen
Yu-Jing Zhang
Yu Tang
Hao Jing
Hui Fang
Jian-Yang Wang
Jiang-Hu Zhang
Xu-Ran Zhao
Si-Ye Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.955381

3,044 views
1 citation

Original Research

Published on 16 Dec 2022

Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose

in Radiation Oncology

Ashley Li Kuan Ong
Kellie Knight
Vanessa Panettieri
Mathew Dimmock
Jeffrey Kit Loong Tuan
Hong Qi Tan
Caroline Wright

Frontiers in Oncology

doi 10.3389/fonc.2022.1084311

3,210 views
5 citations

Perspective

Published on 15 Dec 2022

Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology

in Radiation Oncology

Arman Rahmim
Julia Brosch-Lenz
Ali Fele-Paranj
Fereshteh Yousefirizi
Madjid Soltani
Carlos Uribe
Babak Saboury

Frontiers in Oncology

doi 10.3389/fonc.2022.1062592

9,694 views
46 citations

Review

Published on 15 Dec 2022

Impairment mechanism of nasal mucosa after radiotherapy for nasopharyngeal carcinoma

in Radiation Oncology

Caishan Fang
Yu Zhong
Tengyu Chen
Dan Li
Chunqiao Li
Xiangjun Qi
Junxia Zhu
Ruizhi Wang
Jinxiang Zhu
Shunlan Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.1010131

13,984 views
14 citations

Original Research

Published on 14 Dec 2022

Induction FOLFIRINOX followed by stereotactic body radiation therapy in locally advanced pancreatic cancer

in Radiation Oncology

Jae Hyup Jung
Changhoon Song
In Ho Jung
Jinwoo Ahn
Bomi Kim
Kwangrok Jung
Jong-Chan Lee
Jaihwan Kim
Jin-Hyeok Hwang

Frontiers in Oncology

doi 10.3389/fonc.2022.1050070

3,918 views
3 citations

Original Research

Published on 09 Dec 2022

A human-in-the-loop based Bayesian network approach to improve imbalanced radiation outcomes prediction for hepatocellular cancer patients with stereotactic body radiotherapy

in Radiation Oncology

Yi Luo
Kyle C. Cuneo
Theodore S. Lawrence
Martha M. Matuszak
Laura A. Dawson
Dipesh Niraula
Randall K. Ten Haken
Issam El Naqa

Frontiers in Oncology

doi 10.3389/fonc.2022.1061024

3,023 views
11 citations

Review

Published on 08 Dec 2022

New horizons in modulating the radio-sensitivity of head and neck cancer - 100 years after Warburg’ effect discovery

in Radiation Oncology

Camil Ciprian Mireștean
Roxana Irina Iancu
Dragoș Petru Teodor Iancu

Frontiers in Oncology

doi 10.3389/fonc.2022.908695

4,349 views
14 citations

2,378 articles

articles

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer

Local control and patient reported outcomes after online MR guided stereotactic body radiotherapy of liver metastases

Different meaning of the mean heart dose between 3D-CRT and IMRT for breast cancer radiotherapy

High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes

Machine-learning-based prediction of the effectiveness of the delivered dose by exhale-gated radiotherapy for locally advanced lung cancer: The additional value of geometric over dosimetric parameters alone

A novel hydrogel orthotopic injection model in moderately hypofractionated radiation therapy for prostate cancer: Adaptive degradation and durable imaging

Prediction of portal dosimetry quality assurance results using log files-derived errors and machine learning techniques

Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer

Treatment mode and prognosis of esophageal perforation after radiotherapy in patients with esophageal carcinoma

Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy

Cardiac toxicity in patients with lung cancer receiving thoracic radiotherapy and immunotherapy

Primary squamous cell carcinoma of the breast: A case report and review of the literature

Volumetric modulated arc therapy based total marrow and lymphoid irradiation: Workflow and clinical experience

Re-irradiation of recurrent vertebral metastasis after two previous spinal cord irradiation: A case report

A predictive model for personalization of nanotechnology-based phototherapy in cancer treatment

Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer

A liquid immunogenic fiducial eluter for image-guided radiotherapy

Risk factors to identify the indication for regional nodal irradiation in T1-2N1M0 breast cancer: A joint analysis of 4,243 real-world cases from two institutions

Predictive modelling for late rectal and urinary toxicities after prostate radiotherapy using planned and delivered dose

Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology

Impairment mechanism of nasal mucosa after radiotherapy for nasopharyngeal carcinoma

Induction FOLFIRINOX followed by stereotactic body radiation therapy in locally advanced pancreatic cancer

A human-in-the-loop based Bayesian network approach to improve imbalanced radiation outcomes prediction for hepatocellular cancer patients with stereotactic body radiotherapy

New horizons in modulating the radio-sensitivity of head and neck cancer - 100 years after Warburg’ effect discovery